MEDIX RESOURCES INC
SC 13D, 1998-03-02
HELP SUPPLY SERVICES
Previous: COREL CORP, 10-K405, 1998-03-02
Next: PACIFIC CORINTHIAN VAR SEP ACCT OF PACIFIC CORINTHIAN LIFE I, NSAR-U, 1998-03-02



                      SECURITIES AND EXCHANGE COMMISSION
                            WASHINGTON, D.C. 20549
                                 SCHEDULE 13D
                   Under the Securities Exchange Act of 1934
                               (Amendment No.1)*

                          Medix  Resources,  Inc.
             (formerly  International  Nursing  Services,  Inc.)
                               (Name of Issuer)

                                 COMMON STOCK
                          (Title Class of Securities)

                                  585011 10 9
                                (CUSIP Number)

                 LYLE B. STEWART, ESQ., LYLE B. STEWART, P.C.
         3751 S. QUEBEC STREET, DENVER, COLORADO 80237, (303) 267-0920
   (Name, Address and Telephone Number of Person Authorized to Receive Notices
                              and Communications)


                               February 18,1998
(Date  of  Event  which  Requires  Filing  of  this  Statement)

If  the  filing  person  has  previously  filed a statement on Schedule 13G to
report  the  acquisition  which  is  the  subject of this Schedule 13D, and is
filing  this  schedule because of Rule 13d-l(b)(3) or (4), check the following
box  [  ].

  *  The  remainder  of  this  cover  page shall be filled out for a reporting
person's  initial  filing or initial EDGAR filing on this form with respect to
the  subject  class of securities, and for any subsequent amendment containing
information  which  would  alter  disclosures  provided in a prior cover page.

      The  information  required on the remainder of this cover page shall not
be deemed to be "filed" for the purpose of section 18 of the Securities Act of
1934  ("Act")  or  otherwise subject to the liabilities of that section of the
Act  but shall be subject to all other provisions of the Act (however, see the
Notes).






                                   SCHEDULE 13D


(1)     NAME  OF  REPORTING  PERSON  AND  S.S.  OR  I.R.S. IDENTIFICATION 
        NO.    OF  ABOVE    PERSON:

        JOHN  PETER  YEROS

(2)     CHECK  THE  APPROPRIATE  BOX  IF  A  MEMBER  OF  A  GROUP:

        a.  __

        b.  __

(3)     SEC  USE  ONLY:


(4)     SOURCE  OF  FUNDS:    PF

(5)     CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED  PURSUANT  TO
        ITEMS  2(d)    OR    2(e):
                              __
(6)     CITIZENSHIP  OR  PLACE  OF  ORGANIZATION:      U.S.  Citizen

        NUMBER  OF  SHARES  BENEFICIAL  OWNED  BY  REPORTING  PERSON  WITH:

(7)     SOLE  VOTING   POWER :    1,366,313 shares, of which 1,236,313 shares
                                  are  deemed beneficially  owned because
                                  the  reporting  person  holds  options
                                  and  other  rights  that  would  permit
                                  him  to acquire  such  shares  within 
                                  the  next  60  days 

(8)     SHARED  VOTING  POWER:    0

(9)     SOLE  DISPOSITIVE  POWER: 1,366,313  shares,  of  which  1,236,313
                                  shares  are  deemed  beneficially  owned
                                  because the reporting  person  holds options
                                  and other rights that would permit him to
                                  acquire such shares within the next 60 days

(10)    SHARED  DISPOSITIVE  POWER: 0

(11)    AGGREGATE  AMOUNT 
        BENEFICIALLY  OWNED  BY  
        REPORTING  PERSON:        1,366,313  shares,  of  which  1,236,313
                                  shares  are  deemed  beneficially  owned
                                  because  the  reporting person holds options
                                  and other rights that would permit him  to
                                  acquire such shares within the next 60 days

(12)    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES:
            __

(13)    PERCENT  OF  CLASS  REPRESENTED  BY  AMOUNT  IN  ROW  (11):

            6.4% of Issuer' s outstanding Common  Stock

(14)    TYPE  OF  REPORTING  PERSON:    IN

Item  1.      Security  and  Issuer.
              ---------------------
This  statement  relates  to  shares of the Common Stock ("Common Stock"), par
value  of  $.001  per  share, of Medix Resources, Inc., a Colorado corporation
formerly  named  International  Nursing  Services,  Inc.  (the  "Issuer").
Beneficial  ownership  reported herein includes Common Stock issuable upon the
exercise  of  stock options and warrants issued to the reporting person by the
Issuer.    The  Issuer  maintains its principal executive offices at 360 South
Garfield  Street,  Suite  400,  Denver,  Colorado  80209-3136.

Item  2.        Identity  and  Background.
                -------------------------
(a)  -  (c)   This statement is filed by John P. Yeros (the "Reporting
              Person").    His  business  address  is  360  South
              Garfield   Street, Suite 400, Denver, Colorado 80209-3136. 
              The principal occupation of the Reporting Person is President and
              Chief Executive Officer of the  Issuer.
(b)           During  the  last  five  years, the Reporting Person has not been
              convicted  in  any  criminal  proceeding  (excluding
              traffic  violations  or  similar  misdemeanors).
(e)           During the last five years, the Reporting Person has not been a 
              party to  any  civil  proceeding  of  a  judicial  or
              administrative  body  of competent jurisdiction as a result of
              which he was  or  is  subject  to  a  judgment,  decree,  or
              final  order  enjoining  future  violations  of, or prohibiting or
              mandating  activities  subject  to,  federal  or  state
              securities  laws  or  finding  any violation with respect to 
              such laws.
(f)           The  Reporting  Person  is  a  citizen  of  the  United  States.


Item  3.      Source  and  Amount  of  Funds  or  Other  Consideration.
              --------------------------------------------------------

If  the  Reporting  Person exercises any of the options and warrants that have
been  granted  to  the  Reporting  Person  as part  of  his  compensation  by
the  Issuer,  he  will  use  personal  funds

Item  4.        Purpose  of  Transaction.
                ------------------------
The  Reporting  Person  has acquired and may acquire Common Stock from time to
time  for  personal  investment purposes.

Item  5.      Interest  in  Securities  of  the  Issuer.
              -----------------------------------------

(a)          See  items  (11)  and  (13)  on    page  2  of this Schedule 13D.

(b)          See  items  (7)  through  (10)  on  page  2 of this Schedule 13D.

(c)          None

(d)          None

(e)          Not  applicable


Item    6.       Contracts, Arrangements, Understandings or Relationships with
                 -------------------------------------------------------------
Respect  to  Securities  of  the  Issuer.
    ------------------------------------

None,  other  than  standard  stock  option  agreements and warrant agreements
between  the  Issuer  and  the  Reporting

Person.

Item  7.        Material    Filed  as  Exhibits.      None
                -------------------------------
After reasonable inquiry and to the best of my knowledge and belief, I certify
that  the  information  set  forth  in  this  statement  is true, complete and
correct.


Date:  February  24, 1998
/s/  John  P.  Yeros
- --------------------

John  P.  Yeros





© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission